LONDON, ONTARIO--(Marketwire - October 04, 2007) - Stellar Pharmaceuticals Inc., (TSX VENTURE: SLX) (OTCBB: SLXCF) ("Stellar" or the "Company"), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today provided guidance on expected 3rd quarter results.
